November 12, 2025, saw a filing with the Securities and Exchange Commission that revealed Sierra Summit Advisors LLC’s complete abandonment of Baidu stock. The sale of the 128,915 shares effectively ended the fund’s position in the Chinese tech giant. A modest sum of $11.06 million marks the ‘net change’ – a fancy term that signifies the amount of profit or loss that the fund claims to have incurred.
As the third quarter waned, Seven Grand Managers, with a flourish befitting a master of chess, increased its stake in Galaxy Digital by an additional 750,000 shares. With this maneuver, their total holdings now stand at 2 million shares, valued at a notable $67.6 million. The increase of $40.2 million, based on quarterly pricing, was-naturally-disclosed to the public via an SEC filing. The kind of paperwork that makes you wonder if the money’s made in investments or in creating these official documents.
A recent filing with the Securities and Exchange Commission, that venerable arbiter of all that is public and proper, confirms the rather theatrical curtain fall on Roubaix’s engagement with TriMas. The firm, once a modestholder, sold some 212,822 shares-an act that could be mistaken for a firm’s attempt to exit stage left-estimates place the final tally at a rather neat $6.09 million, derived from average quarterly prices. As of this moment, the portfolio stands as barren as a saint’s cell, with TriMas vanishing entirely from their holdings. One might conclude that in a dance of the stock market, Roubaix has gracefully bowed out just as the orchestra hit the crescendo.
The quarterly report, submitted to the SEC, clearly states that Roubaix Capital had liquidated its entire stake in Chart Industries during the third quarter. The once-substantial holding of 42,136 shares was sold off, reducing the fund’s reported U.S. equity portfolio by $6.9 million. A full liquidation, no less, of what had previously accounted for 3.3% of the fund’s assets.
The enigmatic Roubaix Capital, LLC, in a move as sudden as a thunderclap, liquidated its entire holding in Magnite (MGNI 3.92%), casting 260,735 shares into the void during Q3 2025, per a cryptic scroll filed with the Securities and Exchange Commission on November 12, 2025. The sum? A modest $6,288,928, though the true value lies in the silence that followed. By quarter’s end, no shares of Magnite lingered in the fund’s vaults, as though the company had been swallowed by a black hole of doubt.
Per an SEC 13F filing (the quarterly “Here’s What I Bought While You Weren’t Looking” report), Bearing Point dumped a solid chunk of Sprouts in Q3. The stake’s value nosedived from representing 1.2% of fund AUM to just 0.3%. To put that in perspective: if their portfolio were a salad, Sprouts used to be the arugula. Now it’s the sad parsley garnish no one asked for.
Now, I’ll admit I’ve never owned a single share of CRISPR. My own portfolio resembles a thrift store bin-lots of mystery, minimal value-but I do understand the agony of watching something you love underperform. Take CRISPR’s stock price: up 0.64% over the past year while the S&P 500 zoomed past it like a Tesla on Autopilot. It’s the financial equivalent of being left at the prom while your date goes home with a blockchain ETF.
IVV cuts its fees to a sliver-0.03% versus SPY’s 0.09%. It’s the difference between a clean knife and a rusted blade. Both yield roughly the same dividends, but the cost is a slow bleed over time. For the long-haul investor, it’s a choice between a bullet and a needle.
Both funds, like two gentlemen at a garden party, offer broad exposure to the U.S. consumer staples sector-a realm of companies that peddle essentials from toothpaste to tinned tomatoes. The question is not whether they serve the same tea, but rather which teacup one prefers to sip from. Shall we inspect the china? 🫖
Imagine a musical theater where the lead character (Krane) suddenly triples their bet on a song’s final note. That’s our story. In Q3, Krane’s TME stake ballooned to 19 million shares, now worth $421.6 million. If stocks were opera, this would be the aria before the encore.